Pharmasimple SA announced a private placement of minimum 200 bonds convertible into shares for minimum proceed of €1,000,000 and maximum 2,000 bonds convertible into shares for maximum proceeds of €10,000,000 on August 31, 2021. The transaction will include participation from Alpha Blue Ocean Investment Group. The convertible bonds with a nominal value of €5,000 euros will be subscribed in increments of €500,000, which means that a maximum of 20 tranches, representing a total of 2,000 convertible bonds, may be subscribed until August 27, 2026.